Company Filing History:
Years Active: 2018-2020
Title: Christopher M Smales: Innovator in Mammalian Cell Technology
Introduction
Christopher M Smales is a notable inventor based in Chartham, GB. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing recombinant proteins using mammalian cells. With a total of two patents to his name, Smales has established himself as a key figure in his area of expertise.
Latest Patents
Smales' latest patents include "Means and methods for the generation of mammalian producer cells for the production of recombinant proteins." This invention provides methods for generating mammalian cells characterized by an increased concentration of at least one of miR-15, miR-16, and miR-34, aimed at producing proteins at an industrial scale. Additionally, he holds a patent for a "Rapid method for targeted cell (line) selection," which relates to a process for predicting cell culture performance data of sample cells, as well as a process for isolating said cells.
Career Highlights
Christopher M Smales is currently associated with Lonza Biologics Plc, a leading company in the biotechnology sector. His work focuses on enhancing the efficiency and effectiveness of mammalian cell cultures for protein production, which is crucial for various applications in medicine and research.
Collaborations
Throughout his career, Smales has collaborated with notable colleagues, including Marc Feary and James Rance. These collaborations have likely contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Christopher M Smales is a prominent inventor whose work in mammalian cell technology has the potential to revolutionize protein production. His innovative patents and contributions to the field underscore his importance in biotechnology.